Axogen, Inc. — Director's Dealing 2014

Apr 28, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-01-02

Reporting Person: Gold Mark Stephen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-25	Common Stock	M	5007	$0.27	Acquired	257994	Direct
2014-04-25	Common Stock	M	12000	$2.75	Acquired	269994	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-25	Common Stock	$0.27	M	5007	Disposed	2021-02-24	Common Stock (5007)	Direct
2014-04-25	Common Stock	$2.75	M	12000	Disposed	2018-10-10	Common Stock (12000)	Direct
2014-01-02	Common Stock	$4.81	M	15000	Acquired	2021-01-02	Common Stock (15000)	Direct

Footnotes

F1: These shares include 107,690 shares held by Dr. Gold's wife and 125,523 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.

F2: Annual option grant as compensation for services on the board of directors. Options vest as to 25% of total share amount at the end of each fiscal quarter, becoming fully vested after one year.